FAAH inhibitor 1 5mg

Alternative_Names

NA
CAS

326866-17-5
Purity

>98%
MWt

497.65
Formula

C24H23N3O3S3
Solubility

10 mM in DMSO
Clinical_Information

No Development Reported
Pathway

Neuronal Signaling;Metabolic Enzyme/Protease
Target

FAAH;FAAH
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Identity

HGNC:21197
Gene

FA2H
Long gene name

fatty acid 2-hydroxylase
Synonyms gene
- FAXDC1
- SPG35
Synonyms gene name
- fatty acid hydroxylase domain containing 1
- spastic paraplegia 35 (autosomal recessive)
Synonyms
- FAAH
- FLJ25287
Synonyms name
- fatty acid hydroxylase
GenBank acession
- BC002679
Locus

16q23.1
Discovery year

2003-05-27
Entrez gene record

79152
Pubmed identfication
- 20104589
RefSeq identity
- NM_024306
Classification
- Fatty acid hydroxylase domain containing
VEGA ID

OTTHUMG00000137603